drugset / Trial / NCT04807335
Study of CT001 in Healthy Volunteers
Phase 1
Completed
14 enrolled
Cessatech A/S
Dantrials Aps · collabSmerud Medical Research International AS · collab
RandomizedCrossoverOpen-labelOther
Summary
A phase 1, three arms, cross over comparison study to evaluate bioavailability, pharmacokinetics and safety of intra nasal CT001 in healthy volunteers.
Timeline
- Start
- 2021-03-17
- Primary completion
- 2021-06-02
- Completion
- 2021-06-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CT001 | Unknown | — | Intranasal |
| Comparator | Ketamine | Small molecule | 10 mg | Intravenous |
| Comparator | Sufentanil | Other / unclassified | 10 ug | Intravenous |
Indications
No indication recorded.